SEC Form 4 · accession 0001239241-15-000004
Juno Therapeutics, Inc. · JUNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony B Evnin
Director
Period of report
Jul 27, 2015
Accepted (ET)
Jul 29, 2015 · 11:38 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3,F4 | Jul 27, 2015 | S | 80,740 | $48.26 | D | 146,614 | I | By Funds |
| Common StockF5,F6 | Jul 27, 2015 | S | 146,614 | $47.82 | D | 0 | I | By Funds |
| Common Stock | holding | — | — | — | 75,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP") and VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest") on May 18, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.07 to $49.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) - (6) to this Form 4.
- F3On July 29, 2015, VHCP distributed an aggregate of 493,147 shares of the common stock of the Issuer to its respective partners pro rata based on their respective interests in VHCP (the "VHCP Distribution"). In connection with the VHCP Distribution, VHCP Management, LLC ("VHCP Management"), the general partner of VHCP, recevied an aggregate of 137,148 shares of the Issuer. Dr. Evnin did not receive any shares of the Issuer in connection wtih the VHCP Distribution, and with respect to Dr. Evnin, the VHCP Distribution did not represent a change in beneficial ownership.
- F4Consists of 0 shares held by VHCP and 58,171, shares held by VHCP Co-Invest and 88,443 shares held by VHCP Management. VHCP Management is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.50 to $48.06, inclusive.
- F6Consists of 0 shares held by VHCP, 0 shares held by VHCP Co-Invest and 0 held by VHCP Management. VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.